Detalhe da pesquisa
1.
Minimizing the burden of cancer in the United States: Goals for a high-performing health care system.
CA Cancer J Clin;
69(3): 166-183, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30786025
2.
The American Cancer Society 2035 challenge goal on cancer mortality reduction.
CA Cancer J Clin;
69(5): 351-362, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31066919
3.
Evaluating the Jaccard Similarity Index as a Persistence Measure of Multiple Anal Human Papillomavirus Among Nigerian Men Who Have Sex With Men.
Sex Transm Dis;
49(4): 297-303, 2022 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34840323
4.
Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare Analysis.
Oncologist;
26(7): 579-587, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33783061
5.
A Translational Approach to Cancer Research, Education and Training.
J Cancer Educ;
36(3): 621-629, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31907826
6.
Satisfaction with high-resolution anoscopy for anal cancer screening among men who have sex with men: a cross-sectional survey in Abuja, Nigeria.
BMC Cancer;
20(1): 98, 2020 Feb 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32024521
7.
The role of human papillomavirus in nongenital cancers.
CA Cancer J Clin;
63(1): 57-81, 2013 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23258613
8.
Co-targeting EGFR and IKKß/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
Br J Cancer;
120(3): 306-316, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30585254
9.
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
BMC Cancer;
19(1): 485, 2019 May 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31118072
10.
Genotyping of high-risk anal human papillomavirus (HPV): ion torrent-next generation sequencing vs. linear array.
Virol J;
14(1): 112, 2017 Jun 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28610586
11.
Immunohistochemical and molecular imaging biomarker signature for the prediction of failure site after chemoradiation for head and neck squamous cell carcinoma.
Acta Oncol;
56(11): 1562-1570, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28840766
12.
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN).
Cancer Immunol Immunother;
64(3): 367-79, 2015 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25537079
13.
Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma.
Acta Oncol;
54(9): 1408-15, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26256482
14.
Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC.
Head Neck;
46(5): 1126-1135, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38429897
15.
Disease and toxicity outcomes for a modern cohort of patients with squamous cell carcinoma of cutaneous origin involving the parotid gland: Comparison of volumetric modulated arc therapy and pencil beam scanning proton therapy.
Radiother Oncol;
193: 110112, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38309587
16.
Regionalization of Head and Neck Oncology Tumor Boards: Perspectives of Collaborating Physicians.
OTO Open;
7(1): e18, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36998543
17.
Gross tumor volume margin and local control in p16-positive oropharynx cancer patients treated with intensity modulated proton therapy.
Head Neck;
45(5): 1088-1096, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36840723
18.
Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial.
Cancer;
118(7): 1811-7, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22009819
19.
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.
Lancet Oncol;
12(2): 153-9, 2011 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21233014
20.
Cost-effectiveness of concurrent radiation with cetuximab or chemotherapy in older patients with oropharyngeal cancer.
J Comp Eff Res;
11(8): 595-607, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35543585